标题
The dopamine D3 receptor, a quarter century later
作者
关键词
-
出版物
EUROPEAN JOURNAL OF NEUROSCIENCE
Volume 45, Issue 1, Pages 2-19
出版商
Wiley
发表日期
2016-09-07
DOI
10.1111/ejn.13390
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Y-QA31, a novel dopamine D3 receptor antagonist, exhibits antipsychotic-like properties in preclinical animal models of schizophrenia
- (2016) Xue Sun et al. ACTA PHARMACOLOGICA SINICA
- 1,2,4-Triazolyl octahydropyrrolo[2,3-b]pyrroles: A new series of potent and selective dopamine D3 receptor antagonists
- (2016) Fabrizio Micheli et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design, synthesis and evaluation of bitopic arylpiperazinephenyl-1,2,4-oxadiazoles as preferential dopamine D3 receptor ligands
- (2016) Yongkai Cao et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Novel morpholine scaffolds as selective dopamine (DA) D3 receptor antagonists
- (2016) Fabrizio Micheli et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Improving selectivity of dopamine D3 receptor ligands
- (2016) Marc Capet et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The dopamine D3 receptor antagonist, SR 21502, facilitates extinction of cocaine conditioned place preference
- (2016) E. Galaj et al. DRUG AND ALCOHOL DEPENDENCE
- Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology
- (2016) Jo C. Neill et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression
- (2016) Anthony A. Grace NATURE REVIEWS NEUROSCIENCE
- A selective D3 receptor antagonist YQA14 attenuates methamphetamine-induced behavioral sensitization and conditioned place preference in mice
- (2015) Li Sun et al. ACTA PHARMACOLOGICA SINICA
- Dopamine D3 Receptor Modulates l-DOPA-Induced Dyskinesia by Targeting D1 Receptor-Mediated Striatal Signaling
- (2015) Oscar Solís et al. CEREBRAL CORTEX
- Examining endogenous dopamine in treated schizophrenia using [11C]-(+)-PHNO positron emission tomography: A pilot study
- (2015) Fernando Caravaggio et al. CLINICA CHIMICA ACTA
- Drug development in schizophrenia
- (2015) Donald C. Goff CURRENT OPINION IN PSYCHIATRY
- The selective dopamine D3 receptor antagonist, SR 21502, reduces cue-induced reinstatement of heroin seeking and heroin conditioned place preference in rats
- (2015) Ewa Galaj et al. DRUG AND ALCOHOL DEPENDENCE
- P.3.d.053 Cariprazine as monotherapy for the treatment of schizophrenia patients with predominant negative symptoms: a double-blind, active controlled trial
- (2015) M. Debelle et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Dopamine receptor D1 but not D3 essential for morphine-induced conditioned responses
- (2015) Y.P. Wang et al. GENETICS AND MOLECULAR RESEARCH
- High Affinity Dopamine D3 Receptor (D3R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D3R Knockout Mice
- (2015) Comfort A. Boateng et al. JOURNAL OF MEDICINAL CHEMISTRY
- D3dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia
- (2015) Doris E. Payer et al. NEUROLOGY
- Occupancy of Dopamine D3 and D2 Receptors by Buspirone: A [11C]-(+)-PHNO PET Study in Humans
- (2015) Bernard Le Foll et al. NEUROPSYCHOPHARMACOLOGY
- Antipsychotic binding to the dopamine-3 receptor in humans: A PET study with [11C]-(+)-PHNO
- (2015) Ragy R. Girgis et al. SCHIZOPHRENIA RESEARCH
- The selective dopamine D3receptor antagonist SB-277011A attenuates drug- or food-deprivation reactivation of expression of conditioned place preference for cocaine in male sprague-dawley rats
- (2015) Charles R. Ashby et al. SYNAPSE
- The selective dopamine D3receptor antagonist SB-277011A significantly accelerates extinction to environmental cues associated with cocaine-induced place preference in male sprague-dawley rats
- (2015) Charles R. Ashby et al. SYNAPSE
- The selective dopamine D3receptor antagonist SB-277011-A significantly decreases binge-like consumption of ethanol in C57BL/J6 mice
- (2015) Onarae V. Rice et al. SYNAPSE
- Deficits in Prefrontal Cortical and Extrastriatal Dopamine Release in Schizophrenia
- (2015) Mark Slifstein et al. JAMA Psychiatry
- A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia
- (2014) AnnCatherine M Downing et al. BMC Psychiatry
- A novel dopamine D3 receptor antagonist YQA14 inhibits methamphetamine self-administration and relapse to drug-seeking behaviour in rats
- (2014) Ying Chen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Dopamine D3 Receptor Is Necessary for Ethanol Consumption: An Approach with Buspirone
- (2014) Gian Marco Leggio et al. NEUROPSYCHOPHARMACOLOGY
- Dopamine D3 Receptors in the Basolateral Amygdala and the Lateral Habenula Modulate Cue-Induced Reinstatement of Nicotine Seeking
- (2014) Maram ATM Khaled et al. NEUROPSYCHOPHARMACOLOGY
- The novel dopamine D3 receptor antagonist, SR 21502, reduces cocaine conditioned place preference in rats
- (2014) P. Hachimine et al. NEUROSCIENCE LETTERS
- Glutamatergic abnormalities in schizophrenia: A review of proton MRS findings
- (2014) Eline M.P. Poels et al. SCHIZOPHRENIA RESEARCH
- Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug development
- (2014) Bernard Le Foll et al. Frontiers in Pharmacology
- Cariprazine in Schizophrenia: Clinical Efficacy, Tolerability, and Place in Therapy
- (2013) Leslie Citrome ADVANCES IN THERAPY
- Cariprazine in Bipolar Disorder: Clinical Efficacy, Tolerability, and Place in Therapy
- (2013) Leslie Citrome ADVANCES IN THERAPY
- Dopamine D3 receptor as a new pharmacological target for the treatment of depression
- (2013) Gian Marco Leggio et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The dopamine D3 receptor antagonist YQA14 that inhibits the expression and drug-primed reactivation of morphine-induced conditioned place preference in rats
- (2013) Rongrong Hu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The potential role of dopamine D3 receptor neurotransmission in cognition
- (2013) Shinichiro Nakajima et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Dopamine D3 receptor antagonism—still a therapeutic option for the treatment of schizophrenia
- (2013) Gerhard Gross et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Direct and indirect interactions of the dopamine D3 receptor with glutamate pathways: implications for the treatment of schizophrenia
- (2013) Pierre Sokoloff et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Presynaptic CaMKIIα modulates dopamine D3 receptor activation in striatonigral terminals of the rat brain in a Ca2+ dependent manner
- (2013) Arturo Avalos-Fuentes et al. NEUROPHARMACOLOGY
- Dopamine D3 receptor deletion or blockade attenuates cocaine-induced conditioned place preference in mice
- (2013) Rui Song et al. NEUROPHARMACOLOGY
- Heightened D3 Dopamine Receptor Levels in Cocaine Dependence and Contributions to the Addiction Behavioral Phenotype: A Positron Emission Tomography Study with [11C]-(+)-PHNO
- (2013) Doris E Payer et al. NEUROPSYCHOPHARMACOLOGY
- Ventral Tegmental Area/Midbrain Functional Connectivity and Response to Antipsychotic Medication in Schizophrenia
- (2013) Jennifer A Hadley et al. NEUROPSYCHOPHARMACOLOGY
- Dopamine D3 receptors regulate reconsolidation of cocaine memory
- (2013) Y. Yan et al. NEUROSCIENCE
- The selective D3receptor antagonist SB-277011A attenuates morphine-triggered reactivation of expression of cocaine-induced conditioned place preference
- (2013) Onarae V. Rice et al. SYNAPSE
- Association of dopamine-related genetic loci to dopamine D3 receptor antagonist ABT-925 clinical response
- (2013) A Bhathena et al. Translational Psychiatry
- The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
- (2012) Oliver D. Howes et al. ARCHIVES OF GENERAL PSYCHIATRY
- Cocaine self-administration in dopamine D₃ receptor knockout mice.
- (2012) S. Barak Caine et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Higher Binding of the Dopamine D3 Receptor-Preferring Ligand [11C]-(+)-Propyl-Hexahydro-Naphtho-Oxazin in Methamphetamine Polydrug Users: A Positron Emission Tomography Study
- (2012) I. Boileau et al. JOURNAL OF NEUROSCIENCE
- Mathematical modelling of [11C]-(+)-PHNO human competition studies
- (2012) Graham E. Searle et al. NEUROIMAGE
- D3 dopamine receptors interact with dopamine D1 but not D4 receptors in the GABAergic terminals of the SNr of the rat
- (2012) Refugio Cruz-Trujillo et al. NEUROPHARMACOLOGY
- Occupancy of Brain Dopamine D3 Receptors and Drug Craving: A Translational Approach
- (2012) Manolo Mugnaini et al. NEUROPSYCHOPHARMACOLOGY
- Effects of Chronic Buspirone Treatment on Cocaine Self-Administration
- (2012) Nancy K Mello et al. NEUROPSYCHOPHARMACOLOGY
- Increased vulnerability to cocaine in mice lacking dopamine D3 receptors
- (2012) R. Song et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The 3rd Schizophrenia International Research Society Conference, 14–18 April 2012, Florence, Italy: Summaries of oral sessions
- (2012) Brandon Abbs et al. SCHIZOPHRENIA RESEARCH
- Orbitofrontal Connectivity with Resting-State Networks Is Associated with Midbrain Dopamine D3 Receptor Availability
- (2011) David M. Cole et al. CEREBRAL CORTEX
- Dopamine D3 receptor antagonist SB-277011A inhibits methamphetamine self-administration and methamphetamine-induced reinstatement of drug-seeking in rats
- (2011) Amanda E. Higley et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A Double-Blind, Randomized, Placebo-Controlled Study of the Dopamine D3 Receptor Antagonist ABT-925 in Patients With Acute Schizophrenia
- (2011) Laura Redden et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
- (2011) Bita Moghaddam et al. NEUROPSYCHOPHARMACOLOGY
- Is the Acute NMDA Receptor Hypofunction a Valid Model of Schizophrenia?
- (2011) A. Adell et al. SCHIZOPHRENIA BULLETIN
- Effects of antipsychotics on D3 receptors: A clinical PET study in first episode antipsychotic naive patients with schizophrenia using [11C]-(+)-PHNO
- (2011) Romina Mizrahi et al. SCHIZOPHRENIA RESEARCH
- The acute administration of the selective dopamine D3 receptor antagonist SB-277011A reverses conditioned place aversion produced by naloxone precipitated withdrawal from acute morphine administration in rats
- (2011) Onarae V. Rice et al. SYNAPSE
- Affinity and selectivity of [11C]-(+)-PHNO for the D3 and D2 receptors in the rhesus monkey brain in vivo
- (2011) Jean-Dominique Gallezot et al. SYNAPSE
- Imaging Dopamine D3 Receptors in the Human Brain with Positron Emission Tomography, [11C]PHNO, and a Selective D3 Receptor Antagonist
- (2010) Graham Searle et al. BIOLOGICAL PSYCHIATRY
- Dopamine D1 and D3 receptors are differentially involved in cue-elicited cocaine seeking
- (2010) Liping Chen et al. JOURNAL OF NEUROCHEMISTRY
- PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats
- (2010) Amanda E Higley et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy
- (2010) Andri C. Tziortzi et al. NEUROIMAGE
- In Vivo Binding of Antipsychotics to D3 and D2 Receptors: A PET Study in Baboons with [11C]-(+)-PHNO
- (2010) Ragy R Girgis et al. NEUROPSYCHOPHARMACOLOGY
- Activation of dopamine D3 receptors inhibits reward-related learning induced by cocaine
- (2010) H. Kong et al. NEUROSCIENCE
- Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/C mice as an assay for detection of novel antipsychotics
- (2010) Andrea M. Bradford et al. PSYCHOPHARMACOLOGY
- The Effect of Antipsychotics on the High-Affinity State of D2 and D3 Receptors
- (2009) Ariel Graff-Guerrero et al. ARCHIVES OF GENERAL PSYCHIATRY
- Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease
- (2009) I. Boileau et al. BRAIN
- Locomotor activity induced by MK-801 is enhanced in dopamine D3 receptor knockout mice but suppression by dopamine D3/D2 antagonists does not occur through the dopamine D3 receptor
- (2009) Alex V. Yarkov et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925
- (2009) Ariel Graff-Guerrero et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The selective dopamine D3 receptor antagonist SB 277011-A, but not the partial agonist BP 897, blocks cue-induced reinstatement of nicotine-seeking
- (2009) Maram A. T. M. Khaled et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- 1,2,4-Triazolyl Azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Dopamine D3Receptor Antagonists
- (2009) Fabrizio Micheli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Striatal Dopamine D2/D3 Receptor Availability Is Reduced in Methamphetamine Dependence and Is Linked to Impulsivity
- (2009) B. Lee et al. JOURNAL OF NEUROSCIENCE
- Activity-Dependent Modulation of Limbic Dopamine D3 Receptors by CaMKII
- (2009) Xian-Yu Liu et al. NEURON
- In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice
- (2009) Eugenii A. Rabiner et al. SYNAPSE
- Association of Low Striatal Dopamine D2Receptor Availability With Nicotine Dependence Similar to That Seen With Other Drugs of Abuse
- (2008) Christoph Fehr et al. AMERICAN JOURNAL OF PSYCHIATRY
- Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease
- (2008) Naomi P. Visanji et al. NEUROBIOLOGY OF DISEASE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now